CoChat

Fluorine-18-l-Dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography as a Tool to Localize an Insulinoma or β-Cell Hyperplasia in Adult Patients

Open access
Kauhanen, Saila, Seppänen, Marko, Minn, Heikki, Gullichsen, Risto, Salonen, Anna, Alanen, Kalle, Parkkola, Riitta, Solin, Olof, Bergman, Jörgen, Sane, Timo, Salmi, Jorma, Välimäki, Matti, Nuutila, Pirjo · 2007 · The Journal of Clinical Endocrinology & Metabolism
Cited by 152

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Context and Objective: Fluorine-18-l-dihydroxyphenylalanine (18F-DOPA) positron emission tomography (PET) is a promising method in localizing neuroendocrine tumors. Recently, it has been shown to differentiate focal forms of congenital hyperinsulinism of infancy. The current study was set up to determine the potential of 18F-DOPA PET in identifying the insulin-secreting tumors or β-cell hyperplasia of the pancreas in adults. Patients and Methods: We prospectively studied 10 patients with confirmed hyperinsulinemic hypoglycemia and presumed insulin-secreting tumor using 18F-DOPA PET. Anatomical imaging was performed with computed tomography (CT) and magnetic resonance imaging (MRI). All patients were operated on, and histological verification was available in each case. Semiquantitative PET findings in the pancreas using standardized uptake values were compared to standardized uptake values of seven consecutive patients with nonpancreatic neuroendocrine tumors. Results: By visual inspection of 18F-DOPA PET images, it was possible in nine of 10 patients to localize the pancreatic lesion, subsequently confirmed by histological analysis. 18F-DOPA uptake was enhanced in six of seven solid insulinomas and in the malignant insulinoma and its hepatic metastasis. Two patients with β-cell hyperplasia showed increased focal uptake of 18F-DOPA in the affected areas. As compared to CT or MRI, 18F-DOPA PET was more sensitive in localizing diseased pancreatic tissue. Conclusion: 18F-DOPA PET was useful in most patients with insulinoma and negative CT, MRI, and ultrasound results. In agreement with previous findings in infants, preoperative 18F-DOPA imaging seems to be a method of choice for the detection of β-cell hyperplasia in adults. It should be considered for the detection of insulinoma or β-cell hyperplasia in patients with confirmed hyperinsulinemic hypoglycemias when other diagnostic work-up is negative.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2006-1479

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 31

  1. Service, 1999, Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes., J Clin Endocrinol Metab, 84, 1582
  2. McAuley, 2005, Multimodality preoperative imaging of pancreatic insulinomas., Clin Radiol, 60, 1039, 10.1016/j.crad.2005.06.005 · DOI
  3. Grant, 2005, Insulinoma., Best Pract Res Clin Gastroenterol, 19, 783, 10.1016/j.bpg.2005.05.008 · DOI · Paper page
  4. Carlson, 1987, Nesidioblastosis in an adult: an illustrative case and collective review., Am J Gastroenterol, 82, 566
  5. Hirshberg, 2005, Malignant insulinoma: spectrum of unusual clinical features., Cancer, 104, 264, 10.1002/cncr.21179 · DOI · Paper page
  6. Yakovac, 1971, β-Cell nesidioblastosis in idiopathic hypoglycemia of infancy., J Pediatr, 79, 226, 10.1016/S0022-3476(71)80105-1 · DOI
  7. Chatziioannou, 2001, Imaging and localization of pancreatic insulinomas., Clin Imaging, 25, 275, 10.1016/S0899-7071(01)00290-X · DOI
  8. Eriksson, 2005, Developments in PET for the detection of endocrine tumours., Best Pract Res Clin Endocrinol Metab, 19, 311, 10.1016/j.beem.2004.11.001 · DOI
  9. Ericson, 1977, Accumulation of dopamine in mouse pancreatic B-cells following injection of l-DOPA. Localization to secretory granules and inhibition of insulin secretion., Diabetologia, 13, 117, 10.1007/BF00745138 · DOI
  10. Cegrell, 1968, The occurrence of biogenic monoamines in the mammalian endocrine pancreas., Acta Physiol Scand Suppl, 314, 1
  11. Ahlstrom, 1995, Pancreatic neuroendocrine tumors: diagnosis with PET., Radiology, 195, 333, 10.1148/radiology.195.2.7724749 · doi:10.1148/radiology.195.2.7724749
  12. Eriksson, 2002, The role of PET in localization of neuroendocrine and adrenocortical tumors., Ann NY Acad Sci, 970, 159, 10.1111/j.1749-6632.2002.tb04422.x · DOI · Paper page
  13. Anderson, 2001, 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors., J Nucl Med, 42, 213
  14. Hoegerle, 2001, Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors., Radiology, 220, 373, 10.1148/radiology.220.2.r01au25373 · DOI · Paper page
  15. Hoegerle, 2003, 18F-DOPA positron emission tomography for the detection of glomus tumours., Eur J Nucl Med Mol Imaging, 30, 689, 10.1007/s00259-003-1115-3 · DOI · Paper page
  16. Hoegerle, 2002, Pheochromocytomas: detection with 18F DOPA whole body PET—initial results., Radiology, 222, 507, 10.1148/radiol.2222010622 · DOI · Paper page
  17. Hoegerle, 2001, 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels., Eur J Nucl Med, 28, 64, 10.1007/s002590000404 · DOI · Paper page
  18. Becherer, 2004, Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET., J Nucl Med, 45, 1161
  19. Otonkoski, 2006, Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography., Diabetes, 55, 13, 10.2337/diabetes.55.01.06.db05-1128 · DOI · Paper page
  20. Ribeiro, 2005, Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-l-DOPA., J Nucl Med, 46, 560
  21. Hussain, 2006, The diagnosis of ectopic focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography., J Clin Endocrinol Metab, 91, 2839, 10.1210/jc.2006-0455 · DOI
  22. Bergman, 1994, Electrophilic synthesis of 6–18Ffuoro-L-dopa starting from aqueous-18Ffluoride., J Labelled Comp Radiopharm, 35, 476
  23. Boucher, 2004, Respiratory gating for 3-dimensional PET of the thorax: feasibility and initial results., J Nucl Med, 45, 214
  24. Gazdar, 1988, Expression of neuroendocrine cell markers l-DOPA decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin., Cancer Res, 48, 4078
  25. Lonlay, 2006, Congenital hyperinsulinism: pancreatic [18F]fluoro-l-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion., J Clin Endocrinol Metab, 91, 933, 10.1210/jc.2005-1713 · DOI
  26. Borelli, 1997, Presence of DOPA decarboxylase and its localisation in adult rat pancreatic islet cells., Diabetes Metab, 23, 161
  27. Kaczirek, 2004, The importance of preoperative localisation procedures in organic hyperinsulinism–experience in 67 patients., Wien Klin Wochenschr, 116, 373, 10.1007/BF03040916 · DOI
  28. Hirshberg, 2002, Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure., J Am Coll Surg, 194, 761, 10.1016/S1072-7515(02)01177-8 · DOI · Paper page
  29. Kuzin, 1998, Preoperative and intraoperative topographic diagnosis of insulinomas., World J Surg, 22, 593, 10.1007/s002689900440 · DOI
  30. Jaroszewski, 2004, Laparoscopic localization and resection of insulinomas., Arch Surg, 139, 270, 10.1001/archsurg.139.3.270 · DOI
  31. Assalia, 2004, Laparoscopic pancreatic surgery for islet cell tumors of the pancreas., World J Surg, 28, 1239, 10.1007/s00268-004-7617-8 · DOI

Cited by

See all 152

Metadata

Authors
Kauhanen, S., Seppänen, M., Minn, H., Gullichsen, R., Salonen, A., Alanen, K., Parkkola, R., Solin, O., Bergman, J., Sane, T., Salmi, J., Välimäki, M., & Nuutila, P.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2007-04-01
Volume
92
Issue
4
Pages
1237-1244
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1997869303
Cited by
152
References
4
FWCI
12.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.